High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival.

Added 484 days ago (01.07.2020)
Authors: Kujala J, Hartikainen JM, Tengström M, Sironen R, Kosma VM, Mannermaa A
PubMed id: 32602248
Read article